NCT00385606 2023-03-23
Study of Rofecoxib and Prolonged Constant Infusion of Gemcitabine in the Polychemotherapy Treatment of Advanced NSCLC
National Cancer Institute, Naples
Phase 2/3 Completed
Clinical Trials
7 trialsNCT00140894 2019-09-20
A Study of Rofecoxib in Familial Adenomatous Polyposis (FAP) (0966-205)(TERMINATED)
Merck Sharp & Dohme LLC
Phase 4 Terminated
NCT00038389 2018-11-01
Study of Vioxx and Radiation Therapy for Brainstem Glioma
M.D. Anderson Cancer Center
Phase 1 Terminated
NCT00060476 2017-05-09
Treatment With MK0966 for the Prevention of Prostate Cancer (0966-201)
Merck Sharp & Dohme LLC
Phase 3 Completed
NCT00031863 2013-08-02
Rofecoxib After Surgery in Treating Patients With Stage II or Stage III Colorectal Cancer
National Cancer Institute (NCI)
Phase 3 Completed
NCT00637988 2011-01-21
Barrett's Esophagus - 315 - 3 Way Cross Over
AstraZeneca
Phase 4 Completed
NCT00164892 2005-11-17
Selective COX-II Inhibitor as an Adjuvant Therapy in Patients With Resectable Advanced Stomach Cancer ( Histological Staging ≥ T2N1) - A Multi-Centre Prospective Randomised Controlled Trial
Chinese University of Hong Kong
Phase 3 Unknown